Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity.
about
1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapyHuman papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion.PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cellsUnderstanding resistance to EGFR inhibitors-impact on future treatment strategiesThe epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex.New approaches in angiogenic targeting for colorectal cancer.Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes.IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression.Roles of autophagy in cetuximab-mediated cancer therapy against EGFR.Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab.Developing inhibitors of the epidermal growth factor receptor for cancer treatment.Recombinant chimeric antibody hCAb as a novel anti-human colorectal carcinoma agentTargeting the epidermal growth factor receptorReview article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells.Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1alpha.Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer.Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells.Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptorsRecent developments in colorectal cancer treatment by monoclonal antibodies.The new era in the treatment of advanced colorectal cancer patients: the role of monoclonal antibodies.Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells.Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.The developing trend of monoclonal antibodies in the treatment of colorectal cancer.Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle.Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells.Colorectal cancer in review: the role of the EGFR pathway.The role of epidermal growth factor receptor in cancer metastasis and microenvironment.PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.Calcium-induced apoptosis is delayed by HER1 receptor signalling through the Akt and PLCγ pathways in bladder cancer cells.Autophosphorylation of Akt at threonine 72 and serine 246. A potential mechanism of regulation of Akt kinase activity.Elucidation of apoptosis induced by serum deprivation in cultured conjunctival epithelial cells.Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody.A novel single amino acid deletion caspase-8 mutant in cancer cells that lost proapoptotic activity.Excess reactive oxygen species production mediates monoclonal antibody-induced human embryonic stem cell death via oncosis.Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide.[Immunotherapy of head and neck cancer. Identification of a novel mechanism for anti-EGFR mAb anti-tumor effects].
P2860
Q28476652-4A61A8B2-8AAB-49BB-A7A3-8A29FF40EBD5Q30486597-512772E2-79BE-4976-A2D8-E66B427ED8EAQ33857728-4B654ABE-8644-4E31-ADBB-51550E73336AQ34088424-F146AE58-3801-4469-8977-95A0F6E3A3FAQ34103230-7E1BD1C0-74B5-4349-960D-85C4D2E54C80Q34382785-198DA515-8067-4982-A8E0-5E6A924D92A9Q34411046-C863B5EF-AF00-4DF6-AB32-DD23203630C3Q34451934-36D56352-B746-4590-90EA-045614E661FEQ34519896-568B6FCF-0641-45A1-B4C9-039BD61040F6Q34576155-3222B7F2-58AC-40C7-82D9-4E2606B4C1A4Q35001415-EAB3239B-F5BB-4874-B5BC-B2648F04279FQ35157038-10321780-4ABB-455D-A9C8-8C5C9BB9DB47Q35586920-6138AF9D-E65A-4D25-BD0F-BF7F8D147243Q35828552-171907CC-A33E-4A54-AF09-0BCD1082830BQ36041152-BEF916A6-E207-46C7-87DF-7CECF33ACF22Q36178315-43B9D083-4B5F-457B-B9A1-1223ED02AA1DQ36225230-AACFB0A4-2655-4C31-99A4-8F631E4D3AB7Q36302860-C8AAB167-92C4-4AC0-83EF-0AF8F83CFF1AQ36623480-CA95749E-6366-473F-9446-AEB9EEF7CE6AQ36623600-C123311D-D96C-4DEF-9A5F-5A46213F50B9Q36627254-37F870DE-0250-4BE4-8796-60D2587E1CD7Q36634272-BF36BD5B-67F2-4CD7-AF24-090A26405A21Q36670785-E604D592-2501-45CA-8D8A-EBD2F9C067BFQ36677706-B531B0AD-4612-40EB-8B5A-3295008F9C8DQ36842728-3101D073-A0B3-497C-9D66-F73867D23098Q36879532-546047DD-A365-4741-97E2-7DD161FD37C1Q37662128-8EC96FDE-42B4-4D03-8E04-0048C0F6FDE6Q37679938-F6154B61-704B-47F2-89EF-E667B1575B5AQ38132400-4B038A45-E73B-4896-9F12-2E5C12661AE6Q38584695-8E5EFE42-7B69-47ED-9EEF-79F8BB98F99FQ39630184-AD7FF320-3948-4980-AEED-B01BBF9EDDCDQ40301975-B083540E-6613-48C1-A8DF-FF30D2A70984Q40306063-F0E63C0B-AA8F-4AF2-BDEC-D7186C21B601Q43583339-6432509E-0AD3-4206-89E0-8BB2BE089CCEQ44021482-F3769A7C-9AC2-4A2F-9880-3BCE51C6268CQ46430171-B3998E65-BF73-4340-AE0E-25D27D654BF7Q47872054-B43AF36D-95E0-46FC-B300-76B3BBE42CF0Q54602211-825E94F8-873C-4EF9-BE9B-C1D13A52C443
P2860
Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Induction of apoptosis and act ...... un N-terminal kinase activity.
@en
type
label
Induction of apoptosis and act ...... un N-terminal kinase activity.
@en
prefLabel
Induction of apoptosis and act ...... un N-terminal kinase activity.
@en
P2093
P2860
P356
P1476
Induction of apoptosis and act ...... un N-terminal kinase activity.
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2000.1201
P407
P577
2000-06-01T00:00:00Z
P5875
P6179
1010473631